• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    • Diary
    • NEWS
    • Reports
    Pharmaceuticals & Biotech.
    Sector
    Watch
    P
    Pharmaceuticals & Biotech.
    SECTOR | 18 Sep 2025
    New Ebola outbreak in Congo claims lives; WHO sounds global alarm
    Business Standard
    More than 80 cases and rising deaths have been confirmed in Kasai Province of Congo, with limited resources and remote villages testing response efforts
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 18 Sep 2025
    Man with HIV endured 2-year Covid infection, study reveals new record
    Business Standard
    A Lancet study documents a 41-year-old's persistent Covid infection lasting more than 750 days, raising concerns about viral evolution in immunocompromised patients
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 16 Sep 2025
    Medical device makers ask for extending ITC on services, capital goods
    Business Standard
    Industry body Aimed says proposed balanced reforms could help reduce healthcare costs for consumers
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 15 Sep 2025
    Revised US Biosecure Act Could Unlock Opportunities For Indian Pharma Companies
    Revised US Biosecure Act Could Unlock Opportunities For Indian Pharma Companies
    NDTV Profit
    As US drug makers reduce dependence on Chinese players, Indian CDMOs are poised to capture new opportunities.
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 08 Sep 2025
    Deadlier Than HIV Or Malaria: TB Stays India's Top Infectious Killer, Says Study
    Deadlier Than HIV Or Malaria: TB Stays India's Top Infectious Killer, Says Study
    NDTV Profit
    In contrast to other illnesses such as cancer, and cardiovascular diseases which are more frequent in older populations, TB affects the young.
    Copy LinkShare onShare on Share on Share on
    TB remains India's top infectious killer, deadlier than HIV or malaria
    Business Standard | 08 Sep 2025
    P
    Pharmaceuticals & Biotech.
    SECTOR | 06 Sep 2025
    WHO expands Essential Medicines List to include diabetes, obesity treatments, cystic fibrosis, and cancer drugs
    Business Line
    The updated EML and EMLc (for children) also includes medicines for psoriasis, haemophilia and blood-related disorders
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 05 Sep 2025
    India gears up for GLP-1 generics as WHO lists diabetes drugs as essential
    Business Standard
    WHO adds GLP-1 drugs for type 2 diabetes to its Essential Medicines List, as Indian pharma firms prepare to launch generics amid surging demand and patent expirations
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 04 Sep 2025
    Congo Declares Ebola Virus Outbreak As 15 Deaths Reported
    Congo Declares Ebola Virus Outbreak As 15 Deaths Reported
    NDTV Profit
    Samples tested on Wednesday in the capital, Kinshasa, confirmed the cause of the outbreak as Ebola Zaire, a strain of the Ebola virus.
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 01 Sep 2025
    The Wisdom of Plagues: Book traces lessons not learned from pandemics
    Business Standard
    Covid-19 was the saddest pandemic NYT reporter Donald G McNeil ever covered. Now he shows how outbreaks like AIDS and Ebola foreshadowed the next in patterns, responses, and impact
    Copy LinkShare onShare on Share on Share on
    P
    Pharmaceuticals & Biotech.
    SECTOR | 31 Aug 2025
    Repurposed drug statin found to slow cancer growth, boost treatment support
    Business Standard
    Statins, which help treat high cholesterol, have been found to slow down the growth of colorectal tumours, according to a new study, making researchers consider the possibility of repurposing the drug to support cancer treatment. However, more clinical trials are needed to provide scientific evidence before statins can become part of standard cancer treatment, they said. Drug repurposing, an alternative to the conventional way of developing medicines from scratch, accelerates the pace of discovery since existing medicines and compounds being used for it have already passed safety tests. Owing to a need to reduce the cost of developing drugs, the idea has gained traction in recent years with advances in computing power, artificial intelligence and bioinformatics helping in the identification of new uses for existing drugs more systematically and quickly. Cancer is among the multiple diseases, including rheumatoid arthritis and HIV/AIDS, for which drug repurposing is being...
    Copy LinkShare onShare on Share on Share on
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • JD Cables
    • GK Energy
    • Siddhi Cotspin
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd